Canada’s missing life sciences industrial strategy is leaving economic growth on the table
The federal Biomanufacturing and Life Sciences Strategy, released in 2021, did not result in needed policy changes or alignment of federal departments and investments. In contrast, other top-tier countries place life sciences at the centre of industrial strategies and align the sector with talent, trade, research and development, innovation and infrastructure.
Life sciences innovation is not just about saving lives; it is an economic growth engine. Breakthroughs in biotechnology, pharmaceuticals, medical devices, and digital health strengthen a healthy and productive workforce, attract top talent, and spur economic growth and deve...
Get Innovation & Industry Newsletter
From investment to regulation, the policies, decisions and people working on industry and innovation. Tuesday.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
